NCT04008797 2026-02-27A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid TumorEisai Inc.Phase 1/2 Active not recruiting301 enrolled
NCT05651022 2026-01-13Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid TumorsIndaptus Therapeutics, IncPhase 1/2 Active not recruiting120 enrolled
NCT06521567 2025-11-12A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With CancerGlaxoSmithKlinePhase 1/2 Active not recruiting83 enrolled
NCT06205706 2025-09-19BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid TumorsBioInvent International ABPhase 1/2 Active not recruiting35 enrolled
NCT05057013 2025-08-11A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid TumoursCancer Research UKPhase 1/2 Active not recruiting81 enrolled
NCT06239155 2025-02-25A Phase I/II Study of AST-3424 in Subjects With Advanced Solid TumorsAscentawits Pharmaceuticals, LtdPhase 1/2 Active not recruiting51 enrolled
NCT05595473 2024-11-04A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 with Valganciclovir (VGCV) in Subjects with Hepatocellular CarcinomaRznomics, Inc.Phase 1/2 Active not recruiting42 enrolled
NCT05620134 2024-10-15Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic CancerSalubris Biotherapeutics IncPhase 1/2 Active not recruiting263 enrolled